SPARC, Sun Pharma slide as USFDA rescinds approval to drug
Shares of Sun Pharma Advanced Research Company today fell by almost 3 per cent as the US health regulator has revoked its earlier approval of its new drug application for Elepsia XR, an anti-epileptic drug.
